BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 35674964)

  • 1. Drosophila melanogaster as a Rapid and Reliable In Vivo Infection Model to Study the Emerging Yeast Pathogen Candida auris.
    Wurster S; Albert ND; Kontoyiannis DP
    Methods Mol Biol; 2022; 2517():299-316. PubMed ID: 35674964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drosophila melanogaster as a model to study virulence and azole treatment of the emerging pathogen Candida auris.
    Wurster S; Bandi A; Beyda ND; Albert ND; Raman NM; Raad II; Kontoyiannis DP
    J Antimicrob Chemother; 2019 Jul; 74(7):1904-1910. PubMed ID: 31225606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drosophila melanogaster as a facile model for large-scale studies of virulence mechanisms and antifungal drug efficacy in Candida species.
    Chamilos G; Lionakis MS; Lewis RE; Lopez-Ribot JL; Saville SP; Albert ND; Halder G; Kontoyiannis DP
    J Infect Dis; 2006 Apr; 193(7):1014-22. PubMed ID: 16518764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vivo Skin Colonization and Decolonization Models for Candida auris.
    Herrada J; Gamal A; Long L; Ghannoum MA
    Methods Mol Biol; 2022; 2517():269-285. PubMed ID: 35674962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental Mouse Models of Disseminated Candida auris Infection.
    Xin H; Mohiuddin F; Tran J; Adams A; Eberle K
    mSphere; 2019 Sep; 4(5):. PubMed ID: 31484737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenylyl Cyclase and Protein Kinase A Play Redundant and Distinct Roles in Growth, Differentiation, Antifungal Drug Resistance, and Pathogenicity of
    Kim JS; Lee KT; Lee MH; Cheong E; Bahn YS
    mBio; 2021 Oct; 12(5):e0272921. PubMed ID: 34663094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissemination of Candida auris to deep organs in neonatal murine invasive candidiasis.
    Flores-Maldonado O; González GM; Andrade A; Montoya A; Treviño-Rangel R; Silva-Sánchez A; Becerril-García MA
    Microb Pathog; 2021 Dec; 161(Pt B):105285. PubMed ID: 34774701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Immunocompromised Mouse Model of Candida auris Systemic Infection.
    Herrada J; Roberts K; Gamal A; Long L; Ghannoum MA
    Methods Mol Biol; 2022; 2517():317-328. PubMed ID: 35674965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective Medicines against the Widespread, Emergent, and Multidrugresistant Opportunistic Fungal Pathogen Candida auris: A Breath of Hope.
    Ramos LS; Silva LN; de Mello TP; Frota HF; Branquinha MH; Dos Santos ALS
    Curr Top Med Chem; 2022; 22(16):1297-1305. PubMed ID: 35619311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the Differential Pathogenicity of Candida auris in a Galleria mellonella Infection Model.
    Garcia-Bustos V; Ruiz-Saurí A; Ruiz-Gaitán A; Sigona-Giangreco IA; Cabañero-Navalon MD; Sabalza-Baztán O; Salavert-Lletí M; Tormo MÁ; Pemán J
    Microbiol Spectr; 2021 Sep; 9(1):e0001321. PubMed ID: 34106570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the
    Li J; Coste AT; Bachmann D; Sanglard D; Lamoth F
    Microbiol Spectr; 2021 Dec; 9(3):e0139521. PubMed ID: 34730380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candida auris, a singular emergent pathogenic yeast: its resistance and new therapeutic alternatives.
    Fernandes L; Ribeiro R; Henriques M; Rodrigues ME
    Eur J Clin Microbiol Infect Dis; 2022 Dec; 41(12):1371-1385. PubMed ID: 36198878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing the virulence of four major clades of Candida auris strains using a silkworm infection model: Clade IV isolates had higher virulence than the other clades.
    Kurakado S; Matsumoto Y; Sugita T
    Med Mycol; 2023 Nov; 61(11):. PubMed ID: 37898558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Two-Component Response Regulator Ssk1 and the Mitogen-Activated Protein Kinase Hog1 Control Antifungal Drug Resistance and Cell Wall Architecture of Candida auris.
    Shivarathri R; Jenull S; Stoiber A; Chauhan M; Mazumdar R; Singh A; Nogueira F; Kuchler K; Chowdhary A; Chauhan N
    mSphere; 2020 Oct; 5(5):. PubMed ID: 33055262
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapid evolution of an adaptive multicellular morphology of Candida auris during systemic infection.
    Bing J; Guan Z; Zheng T; Ennis CL; Nobile CJ; Chen C; Chu H; Huang G
    Nat Commun; 2024 Mar; 15(1):2381. PubMed ID: 38493178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Bibliometric Review on
    Villanueva-Lozano H; Trejo-Castro AI; Carrion-Alvarez D; Lozano-Díaz ST; Martinez-Torteya A
    Biomed Res Int; 2023; 2023():2385018. PubMed ID: 37869631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virulence of
    Hernando-Ortiz A; Mateo E; Perez-Rodriguez A; de Groot PWJ; Quindós G; Eraso E
    Virulence; 2021 Dec; 12(1):1063-1075. PubMed ID: 33843456
    [No Abstract]   [Full Text] [Related]  

  • 18. Host defense mechanisms against
    Pechacek J; Lionakis MS
    Expert Rev Anti Infect Ther; 2023; 21(10):1087-1096. PubMed ID: 37753840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation.
    Larkin E; Hager C; Chandra J; Mukherjee PK; Retuerto M; Salem I; Long L; Isham N; Kovanda L; Borroto-Esoda K; Wring S; Angulo D; Ghannoum M
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223375
    [No Abstract]   [Full Text] [Related]  

  • 20. Candida auris: A pathogen difficult to identify, treat, and eradicate and its characteristics in Japanese strains.
    Iguchi S; Itakura Y; Yoshida A; Kamada K; Mizushima R; Arai Y; Uzawa Y; Kikuchi K
    J Infect Chemother; 2019 Oct; 25(10):743-749. PubMed ID: 31257156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.